| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
| Sales | 20 | 120 | 3,520 | 590 | 20 |
| Sales Growth | -83.33% | -96.59% | +496.61% | +2,850.00% | +100.00% |
| Net Income | -14,860 | -13,770 | -14,010 | -3,890 | -1,450 |
| Net Income Growth | -7.92% | +1.71% | -260.15% | -168.28% | +8.23% |
Ainos Inc (AIMD)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.5211 +0.0411 (+8.56%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.4868 -0.0343 (-6.58%) 18:48 ET
for Fri, Mar 14th, 2025
Ainos Inc. is a diversified healthcare company. It engaged in the discovery and development of pharmaceutical and biotech products. The company introduce novel products that actively stimulate and rejuvenate the human body to combat disease and enhance the ability to heal. Ainos Inc., formerly known as Amarillo Biosciences Inc., is based in AMARILLO, TX.
Fiscal Year End Date: 12/31